Radnor Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $900K | Sell |
8,480
-60
| -0.7% | -$6.37K | 0.14% | 166 |
|
|
2025
Q1 | $1.06M | Buy |
8,540
+615
| +8% | +$76.3K | 0.18% | 140 |
|
|
2024
Q4 | $976K | Sell |
7,925
-55
| -0.7% | -$6.77K | 0.16% | 158 |
|
|
2024
Q3 | $889K | Sell |
7,980
-245
| -3% | -$27.3K | 0.13% | 181 |
|
|
2024
Q2 | $878K | Buy |
8,225
+16
| +0.2% | +$1.71K | 0.27% | 84 |
|
|
2024
Q1 | $989K | Hold |
8,209
| – | – | 0.17% | 148 |
|
|
2023
Q4 | $1.01M | Sell |
8,209
-775
| -9% | -$95.4K | 0.19% | 136 |
|
|
2023
Q3 | $1.16M | Buy |
8,984
+200
| +2% | +$25.9K | 0.23% | 110 |
|
|
2023
Q2 | $1.09M | Buy |
+8,784
| New | +$1.09M | 0.47% | 47 |
|